Cambridge-Hopkins Questionnaire for Restless Legs Syndrome (CH-RLSq)
The Cambridge-Hopkins diagnostic questionnaire (CH-RLSq) is a 13-item self-completed screening tool that evaluates the 4 core diagnostic criteria of RLS while systematically excluding common mimics such as positional discomfort and leg cramps. 1
Core Structure and Purpose
The CH-RLSq was specifically designed to enable large-scale RLS diagnosis without requiring a trained interviewer, making it particularly valuable for epidemiological studies and population-based screening. 1
The 13 Questions Address:
The 4 essential diagnostic criteria for RLS: 1
- Urge to move the legs, usually accompanied by uncomfortable sensations
- Symptoms that begin or worsen during rest or inactivity
- Symptoms partially or totally relieved by movement
- Symptoms worse in the evening or at night than during the day
Differential diagnosis items to exclude RLS mimics: 1
- Positional discomfort (symptoms that resolve simply by changing position without continued movement)
- Leg cramps (sudden, painful muscle contractions)
Validation and Performance Characteristics
The CH-RLSq demonstrates strong psychometric properties when validated against expert clinical diagnosis: 2
- Sensitivity: 87.2% for detecting true RLS cases 2
- Specificity: 94.4% for correctly identifying non-RLS individuals 2
- Positive predictive value: 85.5% in population-based samples 2
The questionnaire has been validated across multiple populations, including an Arabic translation showing 71% sensitivity and 100% specificity in Lebanese populations. 3
Clinical Recommendation Status
The American Academy of Sleep Medicine classifies the CH-RLSq as a "Recommended" diagnostic tool because it meets all three Movement Disorder Society criteria: 1
- Utilized in appropriate RLS patient populations
- Applied by multiple independent research teams beyond the original developers
- Demonstrates excellent clinimetric properties in validation studies
Practical Advantages
- Self-administered format eliminates the need for trained interviewers, reducing cost and time burden 1
- Systematic mimic exclusion built into the questionnaire structure improves diagnostic accuracy compared to simple symptom checklists 1
- Validated for population surveys where individual clinical interviews would be impractical 2
Important Caveats
While the CH-RLSq provides excellent screening capability, it remains a questionnaire-based tool rather than a definitive clinical diagnosis. 1 Positive screens should prompt clinical evaluation, particularly to assess iron status (ferritin ≤100 ng/mL or transferrin saturation <20%), identify exacerbating medications, and evaluate for associated conditions like end-stage kidney disease, pregnancy, or peripheral neuropathy. 4
The questionnaire's strength lies in its balance between comprehensive diagnostic coverage and practical feasibility for large-scale use, making it superior to single-question screeners while avoiding the 45-minute administration time required by telephone diagnostic interviews. 1